Ovid Therapeutics Inc.

03/03/2021 | Press release | Distributed by Public on 03/03/2021 06:18

Takeda Secures Global Rights from Ovid Therapeutics to Develop and Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut[...]